Non-Lab Diagnostics: FDA Regulatory Considerations | MoFo Life Sciences

The advent of the COVID-19 rapid antigen test launched at-home diagnostics to the forefront of conversation in the life sciences industry. Many believe this is only the beginning. As...

Related Keywords

William Rinehart ,Utah State University ,Mofo Life Sciences ,Laboratory Developed ,Public Health Service ,Mofo Life ,Federal Food ,Cosmetics Act ,Are Not ,System Regulation ,Device Reporting ,Proposed Rule ,Medical Devices ,Laboratory Developed Tests ,Draft Guidance ,Clinical Laboratories ,Regulatory Oversight ,Consumer Tests ,Drug Admin ,Evaluating Substantial Equivalence ,Premarket Notifications ,Device Manufacturers ,Vitro Diagnostic Device Labeling Requirements ,Antigen Home Use Test Template ,Vitro Diagnostics ,Antigen Diagnostic Tests ,Lessons Learned ,